Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assets

Formed by Sofinnova Partners and former Sanofi executive Frédéric Marrache, Bionyra Pharma emerged from stealth Monday with an initial focus in inflammatory bowel disease and atopic dermatitis.